Coexistent anaplastic and differentiated thyroid carcinoma - An immunohistochemical study

被引:32
作者
Aratake, Y
Nomura, H
Kotani, T
Marutsuka, K
Kobayashi, K
Kuma, K
Miyauchi, A
Okayama, A
Tamura, K
机构
[1] Fukuoka Univ, Dept Internal Med, Fukuoka 8140180, Japan
[2] Miyazaki Univ Hosp, Cent Lab Clin Invest, Miyazaki, Japan
[3] Miyazaki Univ Hosp, Dept Lab Med, Miyazaki, Japan
[4] Miyazaki Univ Hosp, Dept Pathol, Miyazaki, Japan
[5] Ohetsu Hosp, Tokushima, Japan
[6] Kuma Hosp, Kobe, Hyogo, Japan
关键词
immunohistochemistry; anaplastic thyroid carcinoma; Apaf-1; CD26/dipeptidyl peptidase IV; galectin-3; E-cadherin; CD147/extracellular matrix metalloproteinase inducer;
D O I
10.1309/LF3Q1NQKMT2N9KNV
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of the present study vas to clarify the underlying molecules that might contribute to the highly aggressive behavior of anaplastic thyroid carcinoma. We selected 5 cases of anaplastic thyroid carcinoma that had a differentiated areas to determine differences in the molecules of undifferentiated and differentiated cancer cells. We immunohistochemically examined the localization of nuclear antigen (Ki-67), proliferating cell nuclear antigen (PCNA), p53, apoptotic protease-activating factor-1 (Apaf-1), CD26, galectin-3, E-cadherin, and CD147. We found increased Ki-67, PCNA, and p53 labeling indices; decreased levels of Apaf-1, CD26, galectin-3, and E-cadherin; and overexpression of CD147 in the undifferentiated area compared with the differentiated area. These findings indicate high proliferative properties, suppression of opoptosis, disruption of cell-cell interaction, and induction of matrix metalloproteinases in the undifferentiated areas. Thus the molecules examined might be useful for evaluating the aggressive nature Of this tumor and the prognosis.
引用
收藏
页码:399 / 406
页数:8
相关论文
共 53 条
  • [1] Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules
    Aratake, Y
    Umeki, K
    Kiyoyama, K
    Hinoura, Y
    Sato, S
    Ohno, A
    Kuribayashi, T
    Hirai, K
    Nabeshima, K
    Kotani, T
    [J]. DIAGNOSTIC CYTOPATHOLOGY, 2002, 26 (06) : 366 - 372
  • [2] DIPEPTIDYL AMINOPEPTIDASE-IV STAINING OF CYTOLOGIC PREPARATIONS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID-DISEASES
    ARATAKE, Y
    KOTANI, T
    TAMURA, K
    ARAKI, Y
    KURIBAYASHI, T
    KONOE, K
    OHTAKI, S
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (03) : 306 - 310
  • [3] Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression
    Basolo, F
    Pollina, L
    Fontanini, G
    Fiore, L
    Pacini, F
    Baldanzi, A
    [J]. BRITISH JOURNAL OF CANCER, 1997, 75 (04) : 537 - 541
  • [4] BISWAS C, 1995, CANCER RES, V55, P434
  • [5] Bordador LC, 2000, INT J CANCER, V85, P347, DOI 10.1002/(SICI)1097-0215(20000201)85:3<347::AID-IJC9>3.0.CO
  • [6] 2-#
  • [7] BRABANT G, 1993, CANCER RES, V53, P4987
  • [8] Chiappetta G, 2004, ONCOL REP, V12, P239
  • [9] Cvejic D, 1998, ANTICANCER RES, V18, P2637
  • [10] Reduced Apaf-1 expression in human cutaneous melanomas
    Dai, DL
    Martinka, M
    Bush, JA
    Li, G
    [J]. BRITISH JOURNAL OF CANCER, 2004, 91 (06) : 1089 - 1095